Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
F-box and WD repeat domain containing 12 (FBXW12) is a member of the F-box protein family, characterized by the presence of an approximately 40-amino acid F-box motif and WD repeat domains. It acts as a substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex, facilitating the ubiquitin-mediated degradation of target proteins, which is crucial for the regulation of cellular processes such as cell cycle progression, growth, differentiation, and apoptosis[1][2][3]. The gene may play a role in cellular homeostasis, and its altered expression or loss, such as through genetic deletion or promoter methylation, has been associated with ovarian carcinogenesis and neuroblastoma[3]. Additionally, expression of a circular RNA from this locus (circ-FBXW12) promotes pathogenic cell behaviors in diabetic nephropathy, suggesting a function in both malignant and non-malignant disease contexts[3]. There are currently no known drugs that directly target FBXW12, and it is not established as an actionable therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on F-box and WD repeat domain containing 12 (FBXW12).